Home » Topics » BioWorld

BioWorld
RSS

EMISPHERE OFFERING TO BEGIN TRADING

Feb. 10, 1993

CEPHALON FILES SECONDARY

Feb. 10, 1993

CELL GENESYS GETS $10M TO DEVELOP MAbs

Feb. 10, 1993

BIOSYS TO BUY PHEROMONE FIRM

Feb. 10, 1993

HOLLINGS RENTON MOVES TO ONYX

Feb. 10, 1993

CYTOGEN GAINS CANCER MAB LICENSE

Feb. 10, 1993

EPIGEN FILES BROAD PATENT ON CARCINOMA ANTIGEN

Feb. 10, 1993

IMCLONE STARTS CANCER VACCINE TRIALS

Feb. 10, 1993

REGENERON'S SECOND CNTF PATENT ALLOWED

Feb. 10, 1993

HOFFMAN-LAROCHE FACES AIDS ACTIVISTS

Feb. 10, 1993

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...